Medical Care

Global Mitral Regurgitation Market Research Report 2025

The global market for Mitral Regurgitation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mitral regurgitation (MR) is the backflow of blood from the left ventricle into the left atrium during left ventricular systole. The mitral valve is located in the opening between the left atrium and the left ventricle. It opens to allow blood from the left atrium to fill the left ventricle. When the left ventricle contracts, the mitral valve closes so that pumped blood can only flow into the aorta. When the mitral valve is not fully closed, some blood can leak back into the left atrium. Mitral regurgitation can be divided into primary and secondary MR according to the pathogenesis. Primary mitral regurgitation is due to the pathological changes of one or more of the mitral valve leaflets, valve annulus, chordae tendineae and papillary muscles, such as degenerative disease or rheumatic disease, which cause the mitral valve to fail to close normally. Secondary mitral valve regurgitation is functional mitral valve regurgitation, which is caused by the disease of the heart itself or the valve supporting structure, such as pathological changes of the myocardium leading to pathological dilatation of the left ventricle and mitral valve annulus or Mitral regurgitation due to localized displacement of the left ventricle and subvalvular device. The current quantitative assessment of mitral valve regurgitation, the current standards of various guidelines and documents are not completely consistent, generally divided into mild, moderate and severe, this classification is relatively broad, can not well reflect the changes and manifestations before and after surgery effect of surgery. In the MitraClip system clinical trial, mitral regurgitation was divided into no (0+), mild (1+), moderate (2+), moderate to severe (3+), severe (4+), and then more This classification method is used in several clinical studies of mitral valve regurgitation interventional therapy.
North American market for Mitral Regurgitation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mitral Regurgitation is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Mitral Regurgitation in Transapical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Mitral Regurgitation include Edwards Lifesciences, Abbott, CardioSolution, NeoChord, Mitralign, Medtronic, Boston Scientific, Mitralix, Shanghai Hanyu Medical Technology, Valgen Holding Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mitral Regurgitation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mitral Regurgitation.
The Mitral Regurgitation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mitral Regurgitation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mitral Regurgitation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edwards Lifesciences
Abbott
CardioSolution
NeoChord
Mitralign
Medtronic
Boston Scientific
Mitralix
Shanghai Hanyu Medical Technology
Valgen Holding Corporation
NeoChord
CoreMedic
Babic Chord
Gore Medical
Valtech Cardio
Transcardiac
ChoRe
AVVIE
Cardiovalve
HighLife SAS
Neovasc
MitrAssist Lifesciences
Shanghai NewMed Medical
Peijia Medical
MicroPort CardioFlow Medtech
Segment by Type
Primary Mitral Regurgitation
Secondary Mitral Regurgitation
Segment by Application
Transapical
Via Stock and Via Interstitial
Right Internal Jugular Vein
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mitral Regurgitation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mitral Regurgitation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Primary Mitral Regurgitation
1.2.3 Secondary Mitral Regurgitation
1.3 Market by Application
1.3.1 Global Mitral Regurgitation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Transapical
1.3.3 Via Stock and Via Interstitial
1.3.4 Right Internal Jugular Vein
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mitral Regurgitation Market Perspective (2020-2031)
2.2 Global Mitral Regurgitation Growth Trends by Region
2.2.1 Global Mitral Regurgitation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Mitral Regurgitation Historic Market Size by Region (2020-2025)
2.2.3 Mitral Regurgitation Forecasted Market Size by Region (2026-2031)
2.3 Mitral Regurgitation Market Dynamics
2.3.1 Mitral Regurgitation Industry Trends
2.3.2 Mitral Regurgitation Market Drivers
2.3.3 Mitral Regurgitation Market Challenges
2.3.4 Mitral Regurgitation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mitral Regurgitation Players by Revenue
3.1.1 Global Top Mitral Regurgitation Players by Revenue (2020-2025)
3.1.2 Global Mitral Regurgitation Revenue Market Share by Players (2020-2025)
3.2 Global Mitral Regurgitation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mitral Regurgitation Revenue
3.4 Global Mitral Regurgitation Market Concentration Ratio
3.4.1 Global Mitral Regurgitation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mitral Regurgitation Revenue in 2024
3.5 Global Key Players of Mitral Regurgitation Head office and Area Served
3.6 Global Key Players of Mitral Regurgitation, Product and Application
3.7 Global Key Players of Mitral Regurgitation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mitral Regurgitation Breakdown Data by Type
4.1 Global Mitral Regurgitation Historic Market Size by Type (2020-2025)
4.2 Global Mitral Regurgitation Forecasted Market Size by Type (2026-2031)
5 Mitral Regurgitation Breakdown Data by Application
5.1 Global Mitral Regurgitation Historic Market Size by Application (2020-2025)
5.2 Global Mitral Regurgitation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Mitral Regurgitation Market Size (2020-2031)
6.2 North America Mitral Regurgitation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Mitral Regurgitation Market Size by Country (2020-2025)
6.4 North America Mitral Regurgitation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mitral Regurgitation Market Size (2020-2031)
7.2 Europe Mitral Regurgitation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Mitral Regurgitation Market Size by Country (2020-2025)
7.4 Europe Mitral Regurgitation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mitral Regurgitation Market Size (2020-2031)
8.2 Asia-Pacific Mitral Regurgitation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Mitral Regurgitation Market Size by Region (2020-2025)
8.4 Asia-Pacific Mitral Regurgitation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mitral Regurgitation Market Size (2020-2031)
9.2 Latin America Mitral Regurgitation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Mitral Regurgitation Market Size by Country (2020-2025)
9.4 Latin America Mitral Regurgitation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mitral Regurgitation Market Size (2020-2031)
10.2 Middle East & Africa Mitral Regurgitation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Mitral Regurgitation Market Size by Country (2020-2025)
10.4 Middle East & Africa Mitral Regurgitation Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Company Details
11.1.2 Edwards Lifesciences Business Overview
11.1.3 Edwards Lifesciences Mitral Regurgitation Introduction
11.1.4 Edwards Lifesciences Revenue in Mitral Regurgitation Business (2020-2025)
11.1.5 Edwards Lifesciences Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Mitral Regurgitation Introduction
11.2.4 Abbott Revenue in Mitral Regurgitation Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 CardioSolution
11.3.1 CardioSolution Company Details
11.3.2 CardioSolution Business Overview
11.3.3 CardioSolution Mitral Regurgitation Introduction
11.3.4 CardioSolution Revenue in Mitral Regurgitation Business (2020-2025)
11.3.5 CardioSolution Recent Development
11.4 NeoChord
11.4.1 NeoChord Company Details
11.4.2 NeoChord Business Overview
11.4.3 NeoChord Mitral Regurgitation Introduction
11.4.4 NeoChord Revenue in Mitral Regurgitation Business (2020-2025)
11.4.5 NeoChord Recent Development
11.5 Mitralign
11.5.1 Mitralign Company Details
11.5.2 Mitralign Business Overview
11.5.3 Mitralign Mitral Regurgitation Introduction
11.5.4 Mitralign Revenue in Mitral Regurgitation Business (2020-2025)
11.5.5 Mitralign Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Mitral Regurgitation Introduction
11.6.4 Medtronic Revenue in Mitral Regurgitation Business (2020-2025)
11.6.5 Medtronic Recent Development
11.7 Boston Scientific
11.7.1 Boston Scientific Company Details
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Mitral Regurgitation Introduction
11.7.4 Boston Scientific Revenue in Mitral Regurgitation Business (2020-2025)
11.7.5 Boston Scientific Recent Development
11.8 Mitralix
11.8.1 Mitralix Company Details
11.8.2 Mitralix Business Overview
11.8.3 Mitralix Mitral Regurgitation Introduction
11.8.4 Mitralix Revenue in Mitral Regurgitation Business (2020-2025)
11.8.5 Mitralix Recent Development
11.9 Shanghai Hanyu Medical Technology
11.9.1 Shanghai Hanyu Medical Technology Company Details
11.9.2 Shanghai Hanyu Medical Technology Business Overview
11.9.3 Shanghai Hanyu Medical Technology Mitral Regurgitation Introduction
11.9.4 Shanghai Hanyu Medical Technology Revenue in Mitral Regurgitation Business (2020-2025)
11.9.5 Shanghai Hanyu Medical Technology Recent Development
11.10 Valgen Holding Corporation
11.10.1 Valgen Holding Corporation Company Details
11.10.2 Valgen Holding Corporation Business Overview
11.10.3 Valgen Holding Corporation Mitral Regurgitation Introduction
11.10.4 Valgen Holding Corporation Revenue in Mitral Regurgitation Business (2020-2025)
11.10.5 Valgen Holding Corporation Recent Development
11.11 NeoChord
11.11.1 NeoChord Company Details
11.11.2 NeoChord Business Overview
11.11.3 NeoChord Mitral Regurgitation Introduction
11.11.4 NeoChord Revenue in Mitral Regurgitation Business (2020-2025)
11.11.5 NeoChord Recent Development
11.12 CoreMedic
11.12.1 CoreMedic Company Details
11.12.2 CoreMedic Business Overview
11.12.3 CoreMedic Mitral Regurgitation Introduction
11.12.4 CoreMedic Revenue in Mitral Regurgitation Business (2020-2025)
11.12.5 CoreMedic Recent Development
11.13 Babic Chord
11.13.1 Babic Chord Company Details
11.13.2 Babic Chord Business Overview
11.13.3 Babic Chord Mitral Regurgitation Introduction
11.13.4 Babic Chord Revenue in Mitral Regurgitation Business (2020-2025)
11.13.5 Babic Chord Recent Development
11.14 Gore Medical
11.14.1 Gore Medical Company Details
11.14.2 Gore Medical Business Overview
11.14.3 Gore Medical Mitral Regurgitation Introduction
11.14.4 Gore Medical Revenue in Mitral Regurgitation Business (2020-2025)
11.14.5 Gore Medical Recent Development
11.15 Valtech Cardio
11.15.1 Valtech Cardio Company Details
11.15.2 Valtech Cardio Business Overview
11.15.3 Valtech Cardio Mitral Regurgitation Introduction
11.15.4 Valtech Cardio Revenue in Mitral Regurgitation Business (2020-2025)
11.15.5 Valtech Cardio Recent Development
11.16 Transcardiac
11.16.1 Transcardiac Company Details
11.16.2 Transcardiac Business Overview
11.16.3 Transcardiac Mitral Regurgitation Introduction
11.16.4 Transcardiac Revenue in Mitral Regurgitation Business (2020-2025)
11.16.5 Transcardiac Recent Development
11.17 ChoRe
11.17.1 ChoRe Company Details
11.17.2 ChoRe Business Overview
11.17.3 ChoRe Mitral Regurgitation Introduction
11.17.4 ChoRe Revenue in Mitral Regurgitation Business (2020-2025)
11.17.5 ChoRe Recent Development
11.18 AVVIE
11.18.1 AVVIE Company Details
11.18.2 AVVIE Business Overview
11.18.3 AVVIE Mitral Regurgitation Introduction
11.18.4 AVVIE Revenue in Mitral Regurgitation Business (2020-2025)
11.18.5 AVVIE Recent Development
11.19 Cardiovalve
11.19.1 Cardiovalve Company Details
11.19.2 Cardiovalve Business Overview
11.19.3 Cardiovalve Mitral Regurgitation Introduction
11.19.4 Cardiovalve Revenue in Mitral Regurgitation Business (2020-2025)
11.19.5 Cardiovalve Recent Development
11.20 HighLife SAS
11.20.1 HighLife SAS Company Details
11.20.2 HighLife SAS Business Overview
11.20.3 HighLife SAS Mitral Regurgitation Introduction
11.20.4 HighLife SAS Revenue in Mitral Regurgitation Business (2020-2025)
11.20.5 HighLife SAS Recent Development
11.21 Neovasc
11.21.1 Neovasc Company Details
11.21.2 Neovasc Business Overview
11.21.3 Neovasc Mitral Regurgitation Introduction
11.21.4 Neovasc Revenue in Mitral Regurgitation Business (2020-2025)
11.21.5 Neovasc Recent Development
11.22 MitrAssist Lifesciences
11.22.1 MitrAssist Lifesciences Company Details
11.22.2 MitrAssist Lifesciences Business Overview
11.22.3 MitrAssist Lifesciences Mitral Regurgitation Introduction
11.22.4 MitrAssist Lifesciences Revenue in Mitral Regurgitation Business (2020-2025)
11.22.5 MitrAssist Lifesciences Recent Development
11.23 Shanghai NewMed Medical
11.23.1 Shanghai NewMed Medical Company Details
11.23.2 Shanghai NewMed Medical Business Overview
11.23.3 Shanghai NewMed Medical Mitral Regurgitation Introduction
11.23.4 Shanghai NewMed Medical Revenue in Mitral Regurgitation Business (2020-2025)
11.23.5 Shanghai NewMed Medical Recent Development
11.24 Peijia Medical
11.24.1 Peijia Medical Company Details
11.24.2 Peijia Medical Business Overview
11.24.3 Peijia Medical Mitral Regurgitation Introduction
11.24.4 Peijia Medical Revenue in Mitral Regurgitation Business (2020-2025)
11.24.5 Peijia Medical Recent Development
11.25 MicroPort CardioFlow Medtech
11.25.1 MicroPort CardioFlow Medtech Company Details
11.25.2 MicroPort CardioFlow Medtech Business Overview
11.25.3 MicroPort CardioFlow Medtech Mitral Regurgitation Introduction
11.25.4 MicroPort CardioFlow Medtech Revenue in Mitral Regurgitation Business (2020-2025)
11.25.5 MicroPort CardioFlow Medtech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Mitral Regurgitation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Primary Mitral Regurgitation
Table 3. Key Players of Secondary Mitral Regurgitation
Table 4. Global Mitral Regurgitation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Mitral Regurgitation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Mitral Regurgitation Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Mitral Regurgitation Market Share by Region (2020-2025)
Table 8. Global Mitral Regurgitation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Mitral Regurgitation Market Share by Region (2026-2031)
Table 10. Mitral Regurgitation Market Trends
Table 11. Mitral Regurgitation Market Drivers
Table 12. Mitral Regurgitation Market Challenges
Table 13. Mitral Regurgitation Market Restraints
Table 14. Global Mitral Regurgitation Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Mitral Regurgitation Market Share by Players (2020-2025)
Table 16. Global Top Mitral Regurgitation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Regurgitation as of 2024)
Table 17. Ranking of Global Top Mitral Regurgitation Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Mitral Regurgitation Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Mitral Regurgitation, Headquarters and Area Served
Table 20. Global Key Players of Mitral Regurgitation, Product and Application
Table 21. Global Key Players of Mitral Regurgitation, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mitral Regurgitation Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Mitral Regurgitation Revenue Market Share by Type (2020-2025)
Table 25. Global Mitral Regurgitation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Mitral Regurgitation Revenue Market Share by Type (2026-2031)
Table 27. Global Mitral Regurgitation Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Mitral Regurgitation Revenue Market Share by Application (2020-2025)
Table 29. Global Mitral Regurgitation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Mitral Regurgitation Revenue Market Share by Application (2026-2031)
Table 31. North America Mitral Regurgitation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Mitral Regurgitation Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Mitral Regurgitation Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Mitral Regurgitation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Mitral Regurgitation Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Mitral Regurgitation Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Mitral Regurgitation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Mitral Regurgitation Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Mitral Regurgitation Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Mitral Regurgitation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Mitral Regurgitation Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Mitral Regurgitation Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Mitral Regurgitation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Mitral Regurgitation Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Mitral Regurgitation Market Size by Country (2026-2031) & (US$ Million)
Table 46. Edwards Lifesciences Company Details
Table 47. Edwards Lifesciences Business Overview
Table 48. Edwards Lifesciences Mitral Regurgitation Product
Table 49. Edwards Lifesciences Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 50. Edwards Lifesciences Recent Development
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Mitral Regurgitation Product
Table 54. Abbott Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. CardioSolution Company Details
Table 57. CardioSolution Business Overview
Table 58. CardioSolution Mitral Regurgitation Product
Table 59. CardioSolution Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 60. CardioSolution Recent Development
Table 61. NeoChord Company Details
Table 62. NeoChord Business Overview
Table 63. NeoChord Mitral Regurgitation Product
Table 64. NeoChord Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 65. NeoChord Recent Development
Table 66. Mitralign Company Details
Table 67. Mitralign Business Overview
Table 68. Mitralign Mitral Regurgitation Product
Table 69. Mitralign Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 70. Mitralign Recent Development
Table 71. Medtronic Company Details
Table 72. Medtronic Business Overview
Table 73. Medtronic Mitral Regurgitation Product
Table 74. Medtronic Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 75. Medtronic Recent Development
Table 76. Boston Scientific Company Details
Table 77. Boston Scientific Business Overview
Table 78. Boston Scientific Mitral Regurgitation Product
Table 79. Boston Scientific Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 80. Boston Scientific Recent Development
Table 81. Mitralix Company Details
Table 82. Mitralix Business Overview
Table 83. Mitralix Mitral Regurgitation Product
Table 84. Mitralix Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 85. Mitralix Recent Development
Table 86. Shanghai Hanyu Medical Technology Company Details
Table 87. Shanghai Hanyu Medical Technology Business Overview
Table 88. Shanghai Hanyu Medical Technology Mitral Regurgitation Product
Table 89. Shanghai Hanyu Medical Technology Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 90. Shanghai Hanyu Medical Technology Recent Development
Table 91. Valgen Holding Corporation Company Details
Table 92. Valgen Holding Corporation Business Overview
Table 93. Valgen Holding Corporation Mitral Regurgitation Product
Table 94. Valgen Holding Corporation Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 95. Valgen Holding Corporation Recent Development
Table 96. NeoChord Company Details
Table 97. NeoChord Business Overview
Table 98. NeoChord Mitral Regurgitation Product
Table 99. NeoChord Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 100. NeoChord Recent Development
Table 101. CoreMedic Company Details
Table 102. CoreMedic Business Overview
Table 103. CoreMedic Mitral Regurgitation Product
Table 104. CoreMedic Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 105. CoreMedic Recent Development
Table 106. Babic Chord Company Details
Table 107. Babic Chord Business Overview
Table 108. Babic Chord Mitral Regurgitation Product
Table 109. Babic Chord Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 110. Babic Chord Recent Development
Table 111. Gore Medical Company Details
Table 112. Gore Medical Business Overview
Table 113. Gore Medical Mitral Regurgitation Product
Table 114. Gore Medical Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 115. Gore Medical Recent Development
Table 116. Valtech Cardio Company Details
Table 117. Valtech Cardio Business Overview
Table 118. Valtech Cardio Mitral Regurgitation Product
Table 119. Valtech Cardio Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 120. Valtech Cardio Recent Development
Table 121. Transcardiac Company Details
Table 122. Transcardiac Business Overview
Table 123. Transcardiac Mitral Regurgitation Product
Table 124. Transcardiac Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 125. Transcardiac Recent Development
Table 126. ChoRe Company Details
Table 127. ChoRe Business Overview
Table 128. ChoRe Mitral Regurgitation Product
Table 129. ChoRe Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 130. ChoRe Recent Development
Table 131. AVVIE Company Details
Table 132. AVVIE Business Overview
Table 133. AVVIE Mitral Regurgitation Product
Table 134. AVVIE Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 135. AVVIE Recent Development
Table 136. Cardiovalve Company Details
Table 137. Cardiovalve Business Overview
Table 138. Cardiovalve Mitral Regurgitation Product
Table 139. Cardiovalve Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 140. Cardiovalve Recent Development
Table 141. HighLife SAS Company Details
Table 142. HighLife SAS Business Overview
Table 143. HighLife SAS Mitral Regurgitation Product
Table 144. HighLife SAS Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 145. HighLife SAS Recent Development
Table 146. Neovasc Company Details
Table 147. Neovasc Business Overview
Table 148. Neovasc Mitral Regurgitation Product
Table 149. Neovasc Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 150. Neovasc Recent Development
Table 151. MitrAssist Lifesciences Company Details
Table 152. MitrAssist Lifesciences Business Overview
Table 153. MitrAssist Lifesciences Mitral Regurgitation Product
Table 154. MitrAssist Lifesciences Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 155. MitrAssist Lifesciences Recent Development
Table 156. Shanghai NewMed Medical Company Details
Table 157. Shanghai NewMed Medical Business Overview
Table 158. Shanghai NewMed Medical Mitral Regurgitation Product
Table 159. Shanghai NewMed Medical Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 160. Shanghai NewMed Medical Recent Development
Table 161. Peijia Medical Company Details
Table 162. Peijia Medical Business Overview
Table 163. Peijia Medical Mitral Regurgitation Product
Table 164. Peijia Medical Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 165. Peijia Medical Recent Development
Table 166. MicroPort CardioFlow Medtech Company Details
Table 167. MicroPort CardioFlow Medtech Business Overview
Table 168. MicroPort CardioFlow Medtech Mitral Regurgitation Product
Table 169. MicroPort CardioFlow Medtech Revenue in Mitral Regurgitation Business (2020-2025) & (US$ Million)
Table 170. MicroPort CardioFlow Medtech Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. Authors List of This Report


List of Figures
Figure 1. Mitral Regurgitation Picture
Figure 2. Global Mitral Regurgitation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mitral Regurgitation Market Share by Type: 2024 VS 2031
Figure 4. Primary Mitral Regurgitation Features
Figure 5. Secondary Mitral Regurgitation Features
Figure 6. Global Mitral Regurgitation Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Mitral Regurgitation Market Share by Application: 2024 VS 2031
Figure 8. Transapical Case Studies
Figure 9. Via Stock and Via Interstitial Case Studies
Figure 10. Right Internal Jugular Vein Case Studies
Figure 11. Mitral Regurgitation Report Years Considered
Figure 12. Global Mitral Regurgitation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Mitral Regurgitation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Mitral Regurgitation Market Share by Region: 2024 VS 2031
Figure 15. Global Mitral Regurgitation Market Share by Players in 2024
Figure 16. Global Top Mitral Regurgitation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitral Regurgitation as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Mitral Regurgitation Revenue in 2024
Figure 18. North America Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Mitral Regurgitation Market Share by Country (2020-2031)
Figure 20. United States Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Mitral Regurgitation Market Share by Country (2020-2031)
Figure 24. Germany Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Mitral Regurgitation Market Share by Region (2020-2031)
Figure 32. China Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Mitral Regurgitation Market Share by Country (2020-2031)
Figure 40. Mexico Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Mitral Regurgitation Market Share by Country (2020-2031)
Figure 44. Turkey Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Mitral Regurgitation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Edwards Lifesciences Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 48. Abbott Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 49. CardioSolution Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 50. NeoChord Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 51. Mitralign Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 52. Medtronic Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 53. Boston Scientific Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 54. Mitralix Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 55. Shanghai Hanyu Medical Technology Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 56. Valgen Holding Corporation Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 57. NeoChord Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 58. CoreMedic Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 59. Babic Chord Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 60. Gore Medical Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 61. Valtech Cardio Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 62. Transcardiac Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 63. ChoRe Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 64. AVVIE Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 65. Cardiovalve Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 66. HighLife SAS Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 67. Neovasc Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 68. MitrAssist Lifesciences Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 69. Shanghai NewMed Medical Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 70. Peijia Medical Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 71. MicroPort CardioFlow Medtech Revenue Growth Rate in Mitral Regurgitation Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies